Cargando…

Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping

BACKGROUND: Vigilant management of women with high-risk human papillomavirus (hrHPV) is necessary in cancer screening programs. To this end, we evaluated the performance of S5 (targeting DNA methylation in HPV16, HPV18, HPV31, HPV33, and human gene EPB41L3) to predict cervical intraepithelial neopla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hernández-López, Rubí, Lorincz, Attila T., Torres-Ibarra, Leticia, Reuter, Caroline, Scibior-Bentkowska, Dorota, Warman, Rhian, Nedjai, Belinda, Mendiola-Pastrana, Indira, León-Maldonado, Leith, Rivera-Paredez, Berenice, Ramírez-Palacios, Paula, Lazcano-Ponce, Eduardo, Cuzick, Jack, Salmerón, Jorge
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790057/ https://www.ncbi.nlm.nih.gov/pubmed/31606044 http://dx.doi.org/10.1186/s13148-019-0743-9

Ejemplares similares

A comparison of methylation levels in HPV18, HPV31 and HPV33 genomes reveals similar associations with cervical precancers()
por: Vasiljević, Nataša, et al.
Publicado: (2014)

Molecular progression to cervical precancer, epigenetic switch or sequential model?
por: Nedjai, Belinda, et al.
Publicado: (2018)

DNA methylation testing with S5 for triage of high‐risk HPV positive women
por: Adcock, Rachael, et al.
Publicado: (2022)

Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus–Based Screening in Mexico
por: Torres-Ibarra, Leticia, et al.
Publicado: (2019)

Validation of a DNA methylation HPV triage classifier in a screening sample
por: Lorincz, Attila T., et al.
Publicado: (2016)

Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women
por: Vasiljević, Nataša, et al.
Publicado: (2014)

A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
por: Brentnall, Adam R, et al.
Publicado: (2014)

Performance of an affordable urine self-sampling method for human papillomavirus detection in Mexican women
por: Hernández-López, Rubí, et al.
Publicado: (2021)

Methylation of HPV and a tumor suppressor gene reveals anal cancer and precursor lesions
por: Lorincz, Attila T., et al.
Publicado: (2017)

HPV16 L1 and L2 DNA methylation predicts high-grade cervical intraepithelial neoplasia in women with mildly abnormal cervical cytology
por: Lorincz, Attila T, et al.
Publicado: (2013)

Genetic and Epigenetic Variations of HPV52 in Cervical Precancer
por: Bee, Katharine J., et al.
Publicado: (2021)

Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study
por: Allen-Leigh, Betania, et al.
Publicado: (2017)

Factors associated with receiving results and attending colposcopy in patients with positive HPV screens in Mexico City
por: León-Maldonado, Leith, et al.
Publicado: (2023)

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial
por: Cook, Darrel A., et al.
Publicado: (2018)

Perceptions and Experiences of Human Papillomavirus (HPV) Infection and Testing among Low-Income Mexican Women
por: León-Maldonado, Leith, et al.
Publicado: (2016)

Consistency of the S5 DNA methylation classifier in formalin‐fixed biopsies versus corresponding exfoliated cells for the detection of pre‐cancerous cervical lesions
por: Reuter, Caroline, et al.
Publicado: (2021)

Searching HPV genome for methylation sites involved in molecular progression to cervical precancer
por: Kottaridi, Christine, et al.
Publicado: (2019)

Evaluating operational parameters of the careHPV, GeneXpert, AmpFire, and MA-6000 HPV systems for cervical precancer screening: Experience from Battor, Ghana
por: Effah, Kofi, et al.
Publicado: (2023)

Population-based prevalence of cervical infection with human papillomavirus genotypes 16 and 18 and other high risk types in Tlaxcala, Mexico
por: Rudolph, Samantha E., et al.
Publicado: (2016)

Risk Factors for Cervical Precancer and Cancer in HIV-Infected, HPV-Positive Rwandan Women
por: Anastos, Kathryn, et al.
Publicado: (2010)

Human papillomavirus‐based screening at extended intervals missed fewer cervical precancers than cytology in the HPV For Cervical Cancer (HPV FOCAL) trial
por: Gottschlich, Anna, et al.
Publicado: (2022)

HPV testing in primary screening of older women
por: Cuzick, J, et al.
Publicado: (1999)

Women with a positive high-risk human papillomavirus (HPV) test remain at increased risk of HPV infection and cervical precancer ≥15 years later
por: Inturrisi, Federica, et al.
Publicado: (2022)

HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico
por: Flores, Yvonne N., et al.
Publicado: (2010)

Single Nucleotide Polymorphisms in the PRDX3 and RPS19 and Risk of HPV Persistence and Cervical Precancer/Cancer
por: Safaeian, Mahboobeh, et al.
Publicado: (2012)

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era
por: Lehtinen, Matti, et al.
Publicado: (2022)

Increases in HPV-16/18 antibody avidity and HPV-specific memory B-cell response in mid-adult aged men post-dose three of the quadrivalent HPV vaccine
por: Miller, Cheryl N., et al.
Publicado: (2021)

Self-sampling and HPV DNA testing for cervical precancer screening in a cohort of nuns in Ghana: a cross-sectional cohort study
por: Effah, Kofi, et al.
Publicado: (2023)

Detecting cervical precancer and reaching underscreened women by using HPV testing on self samples: updated meta-analyses
por: Arbyn, Marc, et al.
Publicado: (2018)

Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting
por: Landy, Rebecca, et al.
Publicado: (2019)

HPV testing of self-samples: Influence of collection and sample handling procedures on clinical accuracy to detect cervical precancer
por: Arbyn, Marc, et al.
Publicado: (2022)

Roles of extended human papillomavirus genotyping and multiple infections in early detection of cervical precancer and cancer and HPV vaccination
por: Song, Fangbin, et al.
Publicado: (2022)

Cervical precancer screening with HPV DNA testing and mobile colposcopy in women with sickle cell disease in Accra, Ghana
por: Dei-Adomakoh, Yvonne, et al.
Publicado: (2023)

Concurrent HPV DNA testing and a visual inspection method for cervical precancer screening: A practical approach from Battor, Ghana
por: Effah, Kofi, et al.
Publicado: (2023)

Role of quantitative p16(INK4A) mRNA assay and digital reading of p16(INK4A) immunostained sections in diagnosis of cervical intraepithelial neoplasia
por: Vasiljević, Nataša, et al.
Publicado: (2017)

HPV Genotype Specific and Age Stratified Immediate Prevalence of Cervical Precancers and Cancers in Women with NILM/hrHPV+: A Single Center Retrospective Study of 26,228 Cases
por: Liu, Qin, et al.
Publicado: (2021)

Risk of cervical precancer among HPV–negative women in the Netherlands and its association with previous HPV and cytology results: A follow-up analysis of a randomized screening study
por: Inturrisi, Federica, et al.
Publicado: (2022)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

An analysis of HPV infection incidence and clearance by genotype and age in men: The HPV Infection in Men (HIM) Study
por: Ingles, Donna J., et al.
Publicado: (2015)

Cutaneous HPV and alpha-mucosal 9-valent HPV sero-status associations
por: Rahman, Shams, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qqt9m206p94l412gbq3ccc08qa